Evidence map›Paper›PMID 37293314›Full record

ReviewAfrican journal of laboratory medicine2023

Surveillance of antimicrobial resistance in human health in Tanzania: 2016-2021.

Neema Camara, Nyambura Moremi, Janneth Mghamba, Eliudi Eliakimu, Edwin Shumba, Pascale Ondoa, Beverly Egyir

Abstract readReview
In one paragraph

Review in African journal of laboratory medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Prevalence of ESBL-producingOne health (Amsterdam, Netherlands) · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Neema CamaraEpidemiology and Disease Control Section, Ministry of Health, Dodoma, United Republic of Tanzania.ORCID https://orcid.org/0000-0001-9363-1247
Nyambura MoremiDepartment of Bacteriology, National Public Health Laboratory, Dar es Salaam, United Republic of Tanzania.ORCID https://orcid.org/0000-0002-5303-1156
Janneth MghambaEpidemiology and Disease Control Section, Ministry of Health, Dodoma, United Republic of Tanzania.ORCID https://orcid.org/0000-0002-8258-039X
Eliudi EliakimuHealth Quality Assurance Unit, Ministry of Health, Dodoma, United Republic of Tanzania.ORCID https://orcid.org/0000-0003-2383-9530
Edwin ShumbaAfrican Society for Laboratory Medicine, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0002-9942-8490
Pascale OndoaAfrican Society for Laboratory Medicine, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0002-2700-9000
Beverly EgyirDepartment of Bacteriology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Ghana.ORCID https://orcid.org/0000-0002-5032-8739

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Antimicrobial resistance (AMR) surveillance plays an important role in early detection of resistant strains of pathogens and informs treatments decisions at local, regional and national levels. In 2017, Tanzania developed a One Health AMR Surveillance Framework to guide establishment of AMR surveillance systems in the human and animal sectors. Aim: We reviewed AMR surveillance studies in Tanzania to document progress towards establishing an AMR surveillance system and determine effective strengthening strategies. Methods: We conducted a literature review on AMR studies conducted in Tanzania by searching Google Scholar, PubMed, and the websites of the Tanzania Ministry of Health and the World Health Organization for articles written in English and published from January 2012 to March 2021 using relevant search terms. Additionally, we reviewed applicable guidelines, plans, and reports from the Tanzanian Ministry of Health. Results: We reviewed 10 articles on AMR in Tanzania, where studies were conducted at hospitals in seven of Tanzania's 26 regions between 2012 and 2019. Nine AMR sentinel sites had been established, and there was suitable and clear coordination under 'One Health'. However, sharing of surveillance data between sectors had yet to be strengthened. Most studies documented high resistance rates of Gram-negative bacteria to third-generation cephalosporins. There were few laboratory staff who were well trained on AMR. Conclusion: Important progress has been made in establishing a useful, reliable AMR surveillance system. Challenges include a need to develop, implement and build investment case studies for the sustainability of AMR surveillance in Tanzania and ensure proper use of third-generation cephalosporins. What this study adds: This article adds to the knowledge base of AMR trends in Tanzania and progress made in the implementation of AMR surveillance in human health sector as a contribution to the global AMR initiatives to reduce AMR burden worldwide. It has highlighted key gaps that need policy and implementation level attention.

Indexed as

Africaantimicrobial resistanceCOVID-19One HealthsurveillanceTanzania

Identifiers

PMID37293314
PMCPMC10244825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.